recent
develop
pneumonia
caus
origin
wuhan
china
quickli
spread
across
world
report
clinic
characterist
death
case
singl
center
clinic
data
death
case
laboratoryconfirm
infect
obtain
wuhan
local
hospit
electron
medic
record
accord
previous
design
standard
data
collect
form
result
patient
local
resid
wuhan
great
proport
diagnos
sever
ill
admit
death
case
male
half
dead
patient
older
year
median
age
year
bulk
death
case
comorbid
includ
hypertens
heart
diseas
diabet
cerebrovascular
diseas
cancer
respiratori
failur
remain
lead
caus
death
follow
sepsi
syndromemof
cardiac
failur
hemorrhag
renal
failur
furthermor
respiratori
cardiac
hemorrhag
hepat
renal
damag
found
patient
respect
admiss
lymphopenia
neutrophilia
thrombocytopenia
usual
observ
patient
high
neutrophiltolymphocyt
ratio
high
system
immuneinflamm
index
increas
creactiv
protein
level
lactat
dehydrogenas
ddimer
high
level
pgml
observ
detect
patient
median
time
initi
symptom
death
day
signific
associ
aspart
aminotransferas
alanin
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
medrxiv
preprint
aminotransferas
time
initi
symptom
death
interestingli
observ
older
male
comorbid
like
develop
sever
diseas
even
die
infect
respiratori
failur
main
caus
either
viru
cytokin
releas
storm
mediat
damag
organ
includ
cardiac
renal
hepat
hemorrhag
taken
serious
well
bulk
death
case
comorbid
respiratori
failur
remain
lead
caus
death
follow
sepsi
syndromemof
cardiac
failur
hemorrhag
renal
failur
patient
high
neutrophiltolymphocyt
ratio
high
system
immuneinflamm
index
increas
level
proinflammatori
cytokin
caus
cluster
sever
respiratori
ill
similar
anoth
two
fatal
coronaviru
infect
caus
sarscov
merscov
death
like
occur
older
male
patient
comorbid
infect
patient
might
develop
acut
respiratori
distress
respiratori
failur
lead
caus
death
damag
organ
system
includ
cardiac
hemorrhag
hepat
renal
also
contribut
death
damag
might
attribut
indirect
cytokin
storm
initi
immun
system
direct
attack
decemb
first
acut
respiratori
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
sarscov
recent
offici
name
corona
viru
diseas
covid
world
health
organ
occur
wuhan
china
persontoperson
transmiss
identifi
respiratori
droplet
like
fece
februari
confirm
case
close
dead
case
document
china
hundr
import
patient
found
countri
gener
incub
period
day
fever
cough
fatigu
common
symptom
approxim
case
would
develop
sever
ill
need
intervent
intens
care
unit
icu
organ
dysfunct
includ
acut
respiratori
distress
syndrom
ard
shock
acut
cardiac
injuri
acut
renal
injuri
happen
sever
case
report
critic
ill
patient
like
older
underli
diseas
like
symptom
dyspnea
oxygen
therapi
mechan
ventil
intraven
antibiot
antivir
therapi
usual
appli
clinic
manag
present
effect
drug
improv
clinic
outcom
especi
sever
case
ard
rapidli
progress
diseas
main
caus
death
patient
infect
previous
recogn
corona
viru
infect
sarscov
middl
eastern
respiratori
syndrom
coronaviru
merscov
context
initi
consid
lung
commonli
damag
organ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
infect
sinc
human
airway
epithelia
express
angiotensin
convert
enzym
host
cell
receptor
infect
howev
increas
clinic
case
indic
cardiac
renal
even
digest
organ
damag
patient
consist
find
kidney
colon
tissu
also
express
besid
airway
epithelia
clinic
phenomenon
basic
research
suggest
complic
pathogenesi
henc
analyz
clinic
characterist
death
case
urgent
need
improv
outcom
infect
patient
retrospect
collect
epidemiolog
clinic
featur
laboratoryconfirm
dead
patient
januari
februari
renmin
hospit
wuhan
univers
confirm
diagnosi
defin
posit
result
use
realtim
reversetranscriptas
polymerasechainreact
rtpcr
detect
routin
nasal
pharyng
swab
specimen
studi
receiv
approv
research
ethic
committe
renmin
hospit
wuhan
univers
wuhan
china
approv
number
research
ethic
committe
waiv
requir
inform
consent
studi
start
urgent
need
collect
epidemiolog
clinic
data
analyz
data
anonym
clinic
featur
includ
clinic
symptom
sign
laboratori
analys
radiolog
find
treatment
outcom
obtain
hospit
electron
medic
record
accord
previous
design
standard
data
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
collect
form
laboratori
analys
includ
complet
blood
count
liver
function
renal
function
electrolyt
test
coagul
function
creactiv
protein
lactat
dehydrogenas
myocardi
enzym
procalcitonin
statu
viru
infect
radiolog
analys
compris
xray
comput
tomographi
date
onset
symptom
initi
diagnosi
death
record
accur
incub
period
defin
time
contact
transmiss
origin
onset
differ
symptom
sign
onset
surviv
time
defin
period
onset
differ
symptom
sign
time
death
increas
accuraci
collect
data
two
research
independ
review
data
collect
form
also
directli
commun
patient
famili
member
ascertain
epidemiolog
symptom
data
inflamm
marker
calcul
use
specif
paramet
blood
test
neutrophiltolymphocyt
ratio
nlr
calcul
divid
absolut
neutrophil
count
lymphocyt
count
systemat
inflammatori
index
sii
defin
platelet
count
neutrophil
count
lymphocyt
count
interleukin
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
descript
analys
use
determin
patient
epidemiolog
clinic
featur
continu
variabl
present
median
interquartil
rang
iqr
categor
variabl
express
percentag
differ
categori
chisquar
test
fisher
exact
test
adopt
categori
variabl
associ
differ
clinic
variabl
time
initi
symptom
death
evalu
use
spearman
rank
correl
coeffici
statist
analys
studi
perform
use
stata
softwar
stata
corpor
colleg
station
tx
usa
twosid
p
valu
less
consid
statist
signific
januari
februari
total
patient
diagnosi
laboratoryconfirm
record
renmin
hospit
wuhan
univers
patient
diseas
dead
period
rate
mortal
caus
hospit
respect
mortal
rate
higher
p
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
death
case
comorbid
includ
hypertens
heart
diseas
diabet
cerebrovascular
diseas
cancer
dead
patient
underli
diseas
analyz
caus
mortal
patient
laboratoryconfirm
infect
tabl
respiratori
failur
remain
lead
caus
death
follow
sepsi
syndromemultipl
organ
dysfunct
syndrom
mof
cardiac
failur
hemorrhag
renal
failur
furthermor
respiratori
cardiac
hemorrhag
hepat
renal
damag
found
patient
respect
major
patient
damag
organ
system
follow
infect
observ
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
furthermor
last
hour
death
lymphopenia
neutrophilia
thrombocytopenia
continu
present
increas
creactiv
protein
level
high
nlr
increas
lactat
dehydrogenas
increas
ddimer
found
patient
incid
neutrophilia
increas
incid
lymphopenia
reduc
incid
high
creatinin
blood
urea
nitrogen
increas
median
time
initi
symptom
death
day
iqr
signific
associ
aspart
aminotransferas
alanin
aminotransferas
time
initi
symptom
death
interestingli
observ
figur
knowledg
first
studi
describ
clinic
characterist
dead
patient
mortal
current
studi
lower
sar
infect
howev
mortal
rate
center
littl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
bit
higher
previous
report
specul
reason
might
fewer
patient
studi
transfer
icu
time
condit
rapidli
worsen
hand
limit
death
case
less
patient
includ
cohort
much
death
case
includ
present
studi
studi
firstli
focus
epidemiolog
characterist
dead
patient
sever
factor
respons
death
patient
includ
studi
major
patient
older
year
studi
borderlin
signific
associ
age
time
initi
symptom
death
interestingli
observ
result
consist
older
age
like
occur
critic
ill
patient
moreov
found
underli
diseas
hypertens
heart
diseas
diabet
common
death
case
patient
comorbid
featur
consist
previou
report
patient
underli
diseas
like
develop
sever
ill
cancer
patient
compris
cohort
much
higher
cancer
morbid
suggest
cancer
patient
like
develop
sever
diseas
even
death
result
consist
find
nation
wide
analysi
china
immun
defici
viru
infect
seem
common
featur
older
male
comorbid
analyz
caus
death
case
found
respiratori
failur
remain
lead
caus
death
report
bind
receptor
mainli
express
blood
vessel
lung
alveolar
type
ii
epitheli
cell
similar
sarscov
merscov
directli
attack
cell
inde
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patholog
find
indic
infect
lung
present
ard
pulmonari
edema
hyalin
membran
format
evid
desquam
pneumocyt
therefor
find
respiratori
failur
lead
caus
death
consist
underli
patholog
mechan
besid
respiratori
failur
cardiac
failur
hemorrhag
renal
failur
even
mof
also
recogn
caus
death
studi
laboratori
find
also
reveal
cardiac
hepat
renal
damag
patient
also
observ
signific
associ
aspart
aminotransferas
alanin
aminotransferas
time
initi
symptom
death
clinic
phenomena
could
explain
viru
attack
cytokin
releas
storm
cr
mediat
tissu
damag
first
express
also
found
kidney
heart
liver
etc
therefor
could
invad
cell
tissu
reproduc
damag
organ
second
viru
infect
subsequ
tissu
damag
either
lung
target
organ
could
elicit
immun
cell
produc
proinflammatori
cytokin
name
cr
ultim
injuri
tissu
caus
target
organ
failur
obvious
increas
amount
cytokin
includ
monocyt
chemotact
associ
sever
lung
injuri
patient
infect
sarscov
merscov
recent
studi
show
high
level
interferon
induc
protein
occur
serum
patient
infect
probabl
lead
activ
cell
respons
present
report
high
level
creactiv
protein
detect
patient
even
last
hour
prior
death
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
also
depict
immun
statu
patient
sever
ill
patient
studi
present
neutrophilia
lymphopenia
admiss
specif
reduc
tcell
count
observ
patient
high
nlr
also
observ
admiss
hour
death
result
consist
previou
find
found
patient
sever
ill
suggest
perturb
immun
system
contribut
pathogenesi
observ
could
also
explain
older
male
comorbid
like
succumb
studi
limit
firstli
patient
receiv
time
support
intervent
admiss
icu
increas
number
sever
patient
occur
short
period
howev
present
data
could
partial
scenario
patient
progress
natur
pathophysiolog
rather
outcom
intervent
treatment
secondli
consecut
detect
cytokin
lack
fail
truli
monitor
sever
cr
thirdli
organ
damag
could
origin
histori
medic
includ
nonsteroid
antiinflammatori
drug
antibiot
tradit
chines
medicin
associ
renal
liver
injuri
studi
patient
receiv
intraven
antibiot
antiviru
drug
overal
point
view
caus
death
present
clinic
characterist
patient
lung
injuri
begin
insult
lung
epithelium
mainli
attack
express
lung
lead
common
respiratori
failur
organ
tissu
less
potenti
damag
direct
attack
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
addit
damag
multipl
system
includ
lung
might
origin
system
damag
due
cr
follow
infect
consid
pandem
potenti
moder
threaten
popul
multipl
underli
diseas
studi
requir
focu
patholog
pathophysiolog
tissu
injuri
caus
infect
especi
activ
process
immun
respons
cytokin
storm
jw
bz
qs
idea
design
studi
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
bizh
yz
yq
contribut
write
report
bz
contribut
critic
revis
report
jw
bizh
contribut
statist
analysi
author
contribut
data
acquisit
data
analysi
data
interpret
review
approv
final
version
author
declar
compet
interest
data
support
find
studi
avail
correspond
author
reason
request
particip
data
without
name
identifi
made
avail
approv
correspond
author
nation
health
commiss
public
studi
find
data
avail
other
request
research
team
provid
email
address
commun
data
approv
share
other
propos
detail
descript
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
studi
object
statist
analysi
plan
need
evalu
reason
request
data
correspond
author
make
decis
base
materi
addit
materi
may
also
requir
process
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
